Blog
RSS FeedPosted by Michael Wonder on 14 Nov 2024
EMA publishes agenda for 11-14 November 2024 CHMP meeting
11 November 2024 - - The EMA has published a draft agenda for this week's CHMP meeting. ...
Posted by Michael Wonder on 07 Nov 2024
PHARMAC publishes agenda for the November 2024 PTAC meeting
6 November 2024 - PHARMAC has published the agenda for the upcoming 14-15 November 2024 PTAC meeting. ...
Posted by Michael Wonder on 01 Nov 2024
Public Summary Documents – July 2024 PBAC meeting
1 November 2024 - The Public Summary Documents (positive recommendations and subsequent decisions not to recommend) from the July 2024 PBAC ...
Posted by Michael Wonder on 01 Nov 2024
ICER publishes evidence report on treatment for Epstein-Barr virus positive post-transplant lymphoproliferative disease
31 October 2024 - Current evidence suggests that tabelecleucel provides a substantial net health benefit when compared to usual care; ...
Posted by Michael Wonder on 17 Oct 2024
EMA publishes agenda for 14-17 October 2024 CHMP meeting
14 October 2024 - The EMA has published a draft agenda for this week's CHMP meeting. ...
Posted by Michael Wonder on 15 Oct 2024
Agenda for the November 2024 PBAC meeting (version 5)
11 October 2024 - Version 5 of the agenda for the November 2024 PBAC meeting is now available. ...
Posted by Michael Wonder on 01 Oct 2024
Public Summary Documents (first time decisions not to recommend and deferrals) - May 2024 PBAC meeting
1 October 2024 - The Public Summary Documents (first time decisions not to recommend and deferrals) from the May 2024 PBAC ...
Posted by Michael Wonder on 18 Sep 2024
EMA publishes agenda for 16-19 September 2024 CHMP meeting
16 September 2024 - The EMA has published a draft agenda for this week's CHMP meeting. ...
Posted by Michael Wonder on 12 Sep 2024
ICER releases draft evidence report on treatment for Epstein-Barr virus positive post-transplant lymphoproliferative disease
12 September 2024 - Public comment period now open until 8 October 2024; requests to make oral comment during public ...
Posted by Michael Wonder on 11 Sep 2024
Final reports of the HTA Policy and Methods Review and Enhanced Consumer Engagement Process
10 September 2024 - The reports of the HTA Review and the Enhanced Consumer Engagement Process have been published. ...
Posted by Michael Wonder on 06 Sep 2024
Agenda for the November 2024 PBAC meeting (version 4)
6 September 2024 - Version 4 of the agenda for the November 2024 PBAC meeting is now available. ...
Posted by Michael Wonder on 06 Sep 2024
ICER publishes evidence report on treatments for transthyretin amyloid cardiomyopathy
5 September 2024 - Current evidence suggests that tafamidis and acoramidis provide a net health benefit when compared to no ...
Posted by Michael Wonder on 30 Aug 2024
Public Summary Documents – May 2024 PBAC meeting
30 August 2024 - The Public Summary Documents (positive recommendations and subsequent decisions not to recommend) from the May 2024 PBAC ...
Posted by Michael Wonder on 30 Aug 2024
Agenda for the September 2024 PBAC intracycle meeting
30 August 2024 - The agenda for the September 2024 PBAC intracycle meeting is now available. ...
Posted by Michael Wonder on 04 Aug 2024
Agenda for the November 2024 PBAC meeting (version 1)
31 July 2024 - The agenda for the November 2024 PBAC meeting is now available. ...